Palisade Bio, Inc.
USD1.92
+0.01 (+0.52%)
CEO
J. D. Finley
IPO Date
2007-03-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.93
Prev. Close
$1.91
Day Low
$1.91
Day High
$1.98
52W Low
$0.53
52W High
$2.86
Market Cap
$0.33B
Volume
1.63M
| 25,000 |
| $1.96 |
| 8 Jul 2026 | Baltera Robert Jr. | director | P-Purchase | Acquired | 20,000 | $2.05 |
| 8 Jul 2026 | Baltera Robert Jr. | director | P-Purchase | Acquired | 30,000 | $2.03 |
| 8 Jul 2026 | Jones Mitchell Lawrence | Chief Medical Officer | M-Exempt | Acquired | 131,167 | $0.00 |
| 8 Jul 2026 | Jones Mitchell Lawrence | Chief Medical Officer | S-Sale | Disposed | 51,880 | $2.05 |
| 8 Jul 2026 | Jones Mitchell Lawrence | Chief Medical Officer | M-Exempt | Disposed | 131,167 | $0.00 |
| 8 Jul 2026 | Finley John David | director, officer: CEO, CFO | M-Exempt | Acquired | 335,167 | $0.00 |
| 8 Jul 2026 | Finley John David | director, officer: CEO, CFO | S-Sale | Disposed | 146,798 | $2.07 |
| 8 Jul 2026 | Finley John David | director, officer: CEO, CFO | M-Exempt | Acquired | 133 | $0.70 |